ALMU.NASDAQAeluma, INC

Form 4: Aeluma CEO Sells 150K Shares After Bonus Grant

Sentiment:

Insider Transaction Report


Aeluma, Inc. CEO Jonathan Klamkin sold 150,000 shares of common stock for approximately $2.83 million after receiving a bonus grant of restricted stock units and stock options.

Summary

  • Jonathan Klamkin, CEO, Director, and 10% Owner of Aeluma, Inc. (ALMU), reported changes in his beneficial ownership.
  • On July 1, 2025, Klamkin was granted 2,403 Restricted Stock Units (RSUs) and 6,253 stock options as a bonus, both vesting immediately. The RSUs represent the contingent right to receive one share of common stock each, and the stock options have an exercise price of $16.37.
  • On August 14, 2025, Klamkin sold 150,000 shares of Aeluma, Inc. common stock at a weighted average price of $18.8487 per share, totaling approximately $2,827,305.
  • The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Klamkin on May 14, 2025.
  • Following these transactions, Klamkin directly beneficially owns 1,479,398 shares of common stock and 326,253 stock options.

Sentiment

Score: 4

Explanation: The sale of shares by the CEO, while executed under a pre-planned 10b5-1 arrangement, can still be perceived as a slight negative by the market. However, the simultaneous grant of RSUs and stock options as a bonus indicates ongoing compensation and potential alignment with shareholder interests.

Positives

  • CEO Jonathan Klamkin received a bonus grant of 2,403 Restricted Stock Units and 6,253 stock options, indicating board confidence or performance recognition.
  • The bonus RSUs and stock options vested immediately, providing immediate ownership rights.

Negatives

  • CEO Jonathan Klamkin sold 150,000 shares of common stock, which could be perceived negatively by investors as insider selling, even if pre-planned.

Related Party Transactions

  • The grant of 2,403 Restricted Stock Units and 6,253 stock options to Jonathan Klamkin, the CEO, Director, and 10% owner, constitutes a related party transaction as it involves compensation from the company to a key executive and significant shareholder.

Stakeholder Impact

  • Shareholders: The sale of shares by the CEO could lead to concerns about management's confidence, though the 10b5-1 plan mitigates this. The bonus grant aligns management's incentives with long-term share price performance.
  • Employees: The bonus grant to the CEO might set a precedent or reflect a general compensation philosophy within the company.

Key Dates

DateDescription
2025-05-14Date Rule 10b5-1 trading plan was adopted by Jonathan Klamkin.
2025-07-01Date of bonus grant of Restricted Stock Units and Stock Options to Jonathan Klamkin, which vested immediately.
2025-08-14Date of sale of 150,000 shares of common stock by Jonathan Klamkin.

Recommendation

hold

While the CEO's sale of shares might raise some questions, it was conducted under a pre-planned 10b5-1 arrangement, which suggests it's not based on new, negative information. The simultaneous grant of a bonus in the form of RSUs and stock options indicates continued alignment of the CEO's interests with the company's performance. Without further financial or operational details, a "hold" recommendation is appropriate, advising investors to monitor future filings and company performance.

Keywords

Aeluma, ALMU, Jonathan Klamkin, CEO, insider trading, Form 4, stock sale, Rule 10b5-1, restricted stock units, stock options, beneficial ownership, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.